ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
ReShape Announces Positive Preclinical Results for Diabetes Neuromodulation Device americanpharmaceuticalreview
September 17, 2020ReShape Lifesciences announced preclinical research demonstrating the Company's investigational Diabetes Bloc-Stim Neuromodulation? (DBSN?) proprietary device for the treatment of type 2 diabetes mellitus (T2DM) was well-tolerated and met the study ...
Pharma Sources Insight January 2025
